Alpine Immune Sciences, Inc. (ALPN) has a consensus analyst rating of Buy, based on 15 analysts covering the stock. Of those, 9 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for ALPN is $55.00, representing a -15.3% downside from the current price of $64.97. Price targets range from a low of $44.00 to a high of $65.00.
